Press Room

Press release

National Survey Launched to Identify Key Health Concerns Facing Menopausal Women, Duchesnay USA and FabOverFifty.com Join Forces to Elevate the Conversation Surrounding Menopause

Read more >
Press release

Effects of Ospemifene on Genitourinary Health: Prospective Vulvar-Vestibular Photography and Direct Assessments in Post-Menopausal Women

Read more >
Press release

Duchesnay USA Pledges Continued Support of the Mobile Mom Squad through Donations of its Mteryti® and Mteryti® folic 5 Prenatal Supplements

Read more >
Press release

Duchesnay Inc. Receives Approval of Supplemental New Drug Application (sNDA) to Add Moderate to Severe Vaginal Dryness, a Symptom of Vulvar and Vaginal Atrophy (VVA) Due to Menopause, to the Indication of Ospemifene

Read more >
Press release

Duchesnay USA Applauds Expanded Coverage for Treatments for Dyspareunia due to Menopause under Medicare Part D

Read more >
Press release

Duchesnay Inc. Announces Submission of Supplemental New Drug Application (sNDA) for Ospemifene to U.S. FDA

Read more >